Tag: DES
India’s Translumina becomes first company in the world to present 10-year...
Translumina Therapeutics achieved a special feat of becoming the first company in the world to demonstrate a 10-year patient safety and efficacy data of its drug eluting stent, Yukon Choice PC............
AiMeD applauds NPPA for price control on coronary stents
While the Association of Indian Medical Device Industry in a recent letter to the Chairman of National Pharmaceutical Pricing Association has hailed the price control measures, it has also revealed the renewed strategy by the domestic firms...........
MedTech industry needs consensus, not confrontation!
The union government has gone tough on medical technology accessibility and affordability. While the stent prices have been capped, the responsibility to keep them available lies with companies....Read Editor's Take.....